Banfield Bruce W, Kaufman Jessica D, Randall Jessica A, Pickard Gary E
Department of Microbiology, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Campus Box B175, Denver, CO 80262, USA.
J Virol. 2003 Sep;77(18):10106-12. doi: 10.1128/jvi.77.18.10106-10112.2003.
The transsynaptic retrograde transport of the pseudorabies virus Bartha (PRV-Bartha) strain has become an important neuroanatomical tract-tracing technique. Recently, dual viral transneuronal labeling has been introduced by employing recombinant strains of PRV-Bartha engineered to express different reporter proteins. Dual viral transsynaptic tracing has the potential of becoming an extremely powerful method for defining connections of single neurons to multiple neural circuits in the brain. However, the present use of recombinant strains of PRV expressing different reporters that are driven by different promoters, inserted in different regions of the viral genome, and detected by different methods limits the potential of these recombinant virus strains as useful reagents. We previously constructed and characterized PRV152, a PRV-Bartha derivative that expresses the enhanced green fluorescent protein. The development of a strain isogenic to PRV152 and differing only in the fluorescent reporter would have great utility for dual transsynaptic tracing. In this report, we describe the construction, characterization, and application of strain PRV614, a PRV-Bartha derivative expressing a novel monomeric red fluorescent protein, mRFP1. In contrast to viruses expressing DsRed and DsRed2, PRV614 displayed robust fluorescence both in cell culture and in vivo following transsynaptic transport through autonomic circuits afferent to the eye. Transneuronal retrograde dual PRV labeling has the potential to be a powerful addition to the neuroanatomical tools for investigation of neuronal circuits; the use of strain PRV614 in combination with strain PRV152 will eliminate many of the pitfalls associated with the presently used pairs of PRV recombinants.
伪狂犬病病毒巴塔株(PRV - Bartha)的跨突触逆行运输已成为一种重要的神经解剖学示踪技术。最近,通过使用经过基因工程改造以表达不同报告蛋白的PRV - Bartha重组株,引入了双病毒跨神经元标记技术。双病毒跨突触示踪有潜力成为一种极其强大的方法,用于确定单个神经元与大脑中多个神经回路的连接。然而,目前使用的由不同启动子驱动、插入病毒基因组不同区域并通过不同方法检测的表达不同报告蛋白的PRV重组株,限制了这些重组病毒株作为有用试剂的潜力。我们之前构建并鉴定了PRV152,它是一种表达增强型绿色荧光蛋白的PRV - Bartha衍生物。构建一种与PRV152同基因且仅在荧光报告蛋白上不同的毒株,对于双跨突触示踪将具有很大的实用价值。在本报告中,我们描述了PRV614毒株的构建、鉴定及应用,PRV614是一种表达新型单体红色荧光蛋白mRFP1的PRV - Bartha衍生物。与表达DsRed和DsRed2的病毒不同,PRV614在通过传入眼睛的自主神经回路进行跨突触运输后,在细胞培养和体内均显示出强烈的荧光。跨神经元逆行双PRV标记有潜力成为神经解剖学工具中用于研究神经回路的强大补充;将PRV614毒株与PRV152毒株联合使用将消除目前使用的PRV重组毒株对所存在的许多缺陷。